Sleep-disordered breathing and oxidative stress in preclinical chronic mountain sickness (excessive erythrocytosis)
Date
2013-01-22Author
Julian, Colleen Glyde
Vargas, Enrique
Gonzales, Marcelino
Dávila, R Daniela
Ladenburger, Anne
Reardon, Lindsay
Schoo, Caroline
Powers, Robert W
Lee-Chiong, Teofilo
Moore, Lorna G
Metadata
Show full item recordAbstract
Abstract.
Chronic mountain sickness (CMS) is considered to be a loss of ventilatory acclimatization to high
altitude (>2500 m) resulting in marked arterial hypoxemia and polycythemia. This case-control
study explores the possibility that sleep-disordered breathing (SBD) and associated oxidative
stress contribute to the etiology of CMS. Nocturnal respiratory and SaO2 patterns were measured
using standard polysomnography techniques and compared between male high-altitude residents
(aged 18–25) with preclinical CMS ([excessive erythrocytosis (EE)], n=20) and controls (n=19).
Measures of oxidative stress and antioxidant status included isoprostanes (8-iso-PGF2 alpha),
superoxide dismutase and ascorbic acid. EE cases had a greater apnea-hypopnea index, a higher
frequency of apneas (central and obstructive) and hypopneas during REM sleep, and lower
nocturnal SaO2 compared to controls. 8-iso-PGF2alpha was greater in EE than controls, negatively
associated with nocturnal SaO2, and positively associated with hemoglobin concentration. Mild
sleep-disordered breathing and oxidative stress are evident in preclinical CMS, suggesting that the
resolution of nocturnal hypoxemia or antioxidant treatment may prevent disease progression.